Navigate this market better. Subscribe for FREE stock alerts and information.

Monday, October 20, 2014

Actavis, Sanofi among bidders for Omega Pharma - Bloomberg, (NYSE: ACT), (NYSE: PRGO), (NYSE: SNY)

Generic drugmaker Actavis Plc and France's Sanofi SA are among the suitors for privately held Omega Pharma NV, Bloomberg reported, citing people familiar with the matter. Other bidders for the Belgian consumer healthcare company include Perrigo Co and private German drugmaker Boehringer Ingelheim GmBH, the sources told Bloomberg. (bloom.bg/1nxdYbC)Final bid offers are due beginning November, Bloomberg reported, citing the people, who added that the deal could fetch Omega more than 4 billion euros ($5.1 billion).Actavis was not immediately available for comment.Omega Pharma sells prescription-free medicines, healthcare products and over-the-counter items such as wart treatments and sun tan lotions.

Shares of ACT traded higher by 0.86% or $1.94/share to $226.67. In the past year, the shares have traded as low as $143.71 and as high as $249.94. On average, 2423210 shares of ACT exchange hands on a given day and today's volume is recorded at 1699548.

Shares of PRGO traded higher by 1.85% or $2.69/share to $148.47. In the past year, the shares have traded as low as $125.37 and as high as $168.39. On average, 916402 shares of PRGO exchange hands on a given day and today's volume is recorded at 964713.

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. Shares of SNY fell by 0.04% or $-0.02/share to $51.78. In the past year, the shares have traded as low as $47.06 and as high as $57.42. On average, 1144160 shares of SNY exchange hands on a given day and today's volume is recorded at 632637.



Source